SHiMDA:面向 miRNA–疾病关联预测的多图学习元路径建模框架
Robust and comprehensive meta-path modeling with multi-graph learning for miRNA–disease association prediction
SHiMDA 是一个在上下文异质生物医学图上做 miRNA–疾病关联预测的图学习框架,通过为直接关联和具有生物学意义的元路径构建独立视图,并对元路径实例做分段消息传递,显式编码其内部结构而非把每条路径压缩成粗粒度的源–目标捷径。该框架还引入置信度加权排序损失和过平滑正则,以降低图扰动下的监督偏差与表示同质化。在基准数据集上的实验显示,SHiMDA 在基础与上下文设置下均取得较强预测性能,并在对抗性边扰动和特征扰动下持续优于代表性 state-of-the-art 基线。
来源:Briefings in Bioinformatics · doi.org
MicroRNA (miRNA)–disease association prediction is important for biomarker discovery and therapeutic target prioritization. However, existing methods have not adequately captured heterogeneous biological semantics while maintaining robustness under incomplete or perturbed graphs. Therefore, this study aims to develop a robust graph-learning framework that more effectively captures heterogeneous biological semantics. We propose the Semantic Hierarchical Integration for miRNA-Disease Association prediction (SHiMDA) on contextual heterogeneous biomedical graphs. SHiMDA constructs independent views for direct associations and biologically meaningful meta-paths, and performs segment-wise message passing to explicitly encode the internal structure of meta-path instances rather than collapsing each path into a coarse source-target shortcut. A confidence-weighted ranking loss and over-smoothing regularization further reduce supervision bias and representation homogenization under graph perturbations. Extensive experiments on benchmark datasets show that SHiMDA achieves strong predictive performance in basic and contextual settings and consistently outperforms representative state-of-the-art baselines under adversarial edge and feature perturbations. By explicitly modeling segment-wise meta-path semantics and introducing robustness-oriented optimization, SHiMDA improves the reliability of miRNA–disease association prediction under incomplete or perturbed graphs. This work enhances the reliability of computational miRNA–disease association analysis, facilitating more effective biomarker discovery and therapeutic target prioritization in precision medicine.